SLNO/ 09/10/2025 · 1:06 PM Soleno Therapeutics: Patient Death and Vykat XR Scrutiny Soleno's stock dipped after a PWS patient died. Company & doctor say death (pulmonary embolus) was unrelated to VYKAT XR, citing patient's co-morbidities & PWS risks.
